Affinity Asset Advisors, LLC Moderna, Inc. Put Options Transaction History

Affinity Asset Advisors, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $34.1 Million - $46.2 Million	400,000 New	400,000 $42.6 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $3.55 Million - $6.3 Million	30,000 New	30,000 $5.39 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $3.79 Million - $7.05 Million	-30,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $6.77 Million - $11.1 Million	30,000 New	30,000 $7.62 Million

928

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.2B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.